Cargando…
Identifying antepartum patients at risk for developing allergic reactions from COVID-19 monoclonal antibody therapy
Autores principales: | El Sharaiha, Rand, Chen, Katherine, Russell, Kirsten, Azeem, Nabila, Bergman, Celeste, Zarudskaya, Oxana, Khurshid, Nauman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822595/ http://dx.doi.org/10.1016/j.ajog.2022.11.597 |
Ejemplares similares
-
Evaluation of allergic reactions from different monoclonal antibodies used for COVID-19 in pregnancy
por: Chen, Katherine, et al.
Publicado: (2023) -
Evaluation of neonatal outcomes in COVID-19 positive mothers who received monoclonal antibodies
por: Chen, Katherine, et al.
Publicado: (2023) -
547 Neonatal outcomes of COVID-19 positive mothers
por: Zarudskaya, Oxana, et al.
Publicado: (2021) -
Comparing maternal and neonatal adverse outcomes in antepartum versus intrapartum COVID-19 infections
por: Chartier, Anthony, et al.
Publicado: (2023) -
159 Utility of universal preadmission COVID-19 testing in labor and delivery unit at local community hospital
por: Zarudskaya, Oxana, et al.
Publicado: (2021)